tirzepatide ketoacidosis as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real‐World Evidence - Acucella - 2026 - Endocrinology, Diabetes & Metabolism Causes and consequences of discontinuation

Reports have described issues like contamination, poor refrigeration during shipping, and products that dont contain the labeled amount of the active ingredient

gray-market loading then maintenance injection conventions circulate online but are unlicensed, non-standardized, and unsupported by trial data

A previous drug blocking the receptor, known as rimonabant, had led to depression, anxiety and even suicidal thoughts, and was thus withdrawn from the market after less than three years

More than half of insured U.S

The price gap between compounded ($200-$400) and LillyDirect ($350-$550) is real, but so is the regulatory gap

Research protocols examining cagrilintide 10mg formulations demonstrate the importance of proper reconstitution and storage for maintaining peptide integrity